31-45 of 266
RNAi Therapeutics in ATTR-CM: Clinical Evidence and Potential Impacts
On the Frontlines of ATTR-CMRNAi Therapeutics in ATTR-CM: Clinical Evidence and Potential Impacts
Shelina Ramnarine, PhD
Chadi Alraies, MD, MPH, FACC
Strengthening Global Infrastructure for FSHD Trials
AudioAbstractsStrengthening Global Infrastructure for FSHD Trials
Marlene Mimi Maeusli, PhD.
Advancing Relapse Prediction in Pediatric AML Through Genomic MRD
On the Frontlines of AML/ALLAdvancing Relapse Prediction in Pediatric AML Through Genomic MRD
Ryan Quigley
Amanda Winters, MD, PhD
Spinal Muscular Atrophy Reveals Hidden Kidney Impairment Risk
NeuroFrontiersSpinal Muscular Atrophy Reveals Hidden Kidney Impairment Risk
Switching to Risdiplam Maintains Motor Gains in SMA Patients
AudioAbstractsSwitching to Risdiplam Maintains Motor Gains in SMA Patients
Ryan Quigley
GFAP and VEGF Trajectories in Adult Type 3 Spinal Muscular Atrophy Under Nusinersen
NeuroFrontiersGFAP and VEGF Trajectories in Adult Type 3 Spinal Muscular Atrophy Under Nusinersen
- advertisement
Rethinking Acne Pathogenesis with a New Genetic Framework
Clinician's RoundtableRethinking Acne Pathogenesis with a New Genetic Framework
Tracking Early Immunotherapy Response in mTNBC Using cfDNA-Based Copy-Number Profiling
Project Oncology®Tracking Early Immunotherapy Response in mTNBC Using cfDNA-Based Copy-Number Profiling
Tracking Lineage Infidelity in Pediatric B-ALL: New Insights From ASH
Project Oncology®Tracking Lineage Infidelity in Pediatric B-ALL: New Insights From ASH
Ryan Quigley
Kathrin M. Bernt, MD
Rushabh Mehta, BS
Fatemeh Alikarami
Beyond the Cure: Addressing Psychosocial Needs in Gene Therapy for SCD
Project Oncology®Beyond the Cure: Addressing Psychosocial Needs in Gene Therapy for SCD
Victoria Coleman-Cowger, PhD
"I think we're the bridge between the healthcare systems, the pharma systems, and the molecular diagnostic systems," says Matt Newman with Manifold
The Convergence"I think we're the bridge between the healthcare systems, the pharma systems, and the molecular diagnostic systems," says Matt Newman with Manifold
Brian P. McDonough, MD, FAAFP
Matthew Newman
Predicting Prognosis in DLBCL: The Role of Immune-Related Gene Signatures
Project Oncology®Predicting Prognosis in DLBCL: The Role of Immune-Related Gene Signatures
- advertisement
Exploring Patient Perspectives on Genetic Testing for ATTR-CM
On the Frontlines of ATTR-CMExploring Patient Perspectives on Genetic Testing for ATTR-CM
Shelina Ramnarine, PhD
Quan Bui, MD
Navigating Genetic Testing in Kidney Transplants: Clinical and Ethical Issues
Clinician's RoundtableNavigating Genetic Testing in Kidney Transplants: Clinical and Ethical Issues
Elisa J. Gordon, PhD, MPH
Diagnosing and Treating Hemochromatosis: Expert Insights
GI InsightsDiagnosing and Treating Hemochromatosis: Expert Insights
Peter Buch, MD, FACG, AGAF, FACP
Paul Adams, MD